消息
×
loading..
中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 蒋华良

    合作成果数：9

  • 王亚芳

    合作成果数：8

  • 程建军

    合作成果数：5

  • 闫文仲

    合作成果数：4

  • Shen, Jie

    合作成果数：4

访问统计


  总访问量
 600
  访问来源
    内部： 0
    外部： 600
    国内： 549
    国外： 51

  年访问量
 160
  访问来源
    内部： 0
    外部： 160
    国内： 150
    国外： 10

  月访问量
 3
  访问来源
    内部： 0
    外部： 3
    国内： 3
    国外： 0

访问量

访问量

1. Discovery, structural optimization, and anti-tumor bioactivity eva.. [573]
2. 五环三萜衍生物的医药用途、五环三萜衍生物、包含其的药物组合物 [537]
3. 三唑酰胺类化合物及其制备方法和用途 [466]
4. Design and Synthesis of Triazole-Containing HDAC Inhibitors That I.. [437]
5. Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance th.. [399]
6. Discovery of Novel BCL6-Targeting PROTACs with Effective Antitumor.. [389]
7. 嘧啶并环类化合物、其制备方法和应用 [384]
8. Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Rele.. [377]
9. 三唑酰胺类化合物及其制备方法和用途 [372]
10. SOS1蛋白降解剂及其应用 [370]
11. 143D, a novel selective KRASG12C inhibitor exhibits potent antitum.. [348]
12. Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity a.. [202]
13. Mutation in CDC42 Gene Set as a Response Biomarker for Immune Chec.. [139]
14. Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity a.. [111]
15. IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inh.. [104]

下载量

1. Discovery of Novel BCL6-Targeting PROTACs with Effective Antitumor.. [13]
2. Discovery, structural optimization, and anti-tumor bioactivity eva.. [8]
3. Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity a.. [8]
4. Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity a.. [8]
5. Design and Synthesis of Triazole-Containing HDAC Inhibitors That I.. [7]
6. Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance th.. [5]
7. IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inh.. [5]
8. 143D, a novel selective KRASG12C inhibitor exhibits potent antitum.. [4]
9. Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Rele.. [3]
10. 五环三萜衍生物的医药用途、五环三萜衍生物、包含其的药物组合物 [1]
11. Mutation in CDC42 Gene Set as a Response Biomarker for Immune Chec.. [1]